Advanced Ovarian Cancer Clinical Trials
Links shared publicly online about this topic
EGEN, Inc. Announces That Phase II Clinical Trial For Advanced Ovarian Cancer Is Open For Enrollment
medicalnewstoday.com — “EGEN, Inc. announced that the first Phase II clinical trial utilizing EGEN-001 for the treatment of recurrent ovarian cancer is now open for enrollment. The trial is sponsored by the Gynecologic” View full resource at medicalnewstoday.com
Most Recently Shared on December 15, 2010 at 6:05 pm By:
MNT Ovarian Cancer Health News
EGEN, Inc. Announces That Phase II Clinical Trial For Advanced Ovarian Cancer Is Open For Enrollment http://mnt.to/3P6r #ovariancancer
Clinical trial to assess 6MP drug in women with advanced breast or ovarian cancer
news-medical.net — “A CANCER RESEARCH UK-funded trial of a new drug for patients with advanced breast or ovarian cancer due to inherited gene faults has been launched at the Oxford Experimental Cancer Medicine Centre (ECMC) at the University of Oxford.” View full resource at news-medical.net
Most Recently Shared on August 17, 2011 at 11:55 am By:
Ovarian Cancer News: Clinical trial to assess 6MP drug in women with advanced breast or ovarian cancer: A CANCER... http://t.co/to3YUOd
Ovarian Cancer Drug Shows Promise With Move To Phase 3 Trial
medicalnewstoday.com — “A new drug designed to arrest cancer cell growth by inhibiting blood vessel formation in ovarian cancer patients is being readied for a phase 3 trial in Australia, Canada and Europe. The” View full resource at medicalnewstoday.com
Most Recently Shared on November 10, 2010 at 6:05 pm By:
MNT Ovarian Cancer Health News
Ovarian Cancer Drug Shows Promise With Move To Phase 3 Trial http://mnt.to/3MmS #ovariancancer
MabCure Launches Clinical Trial To Diagnose Ovarian Cancer
medicalnewstoday.com — “Mabcure, n.v. (mabcure) a wholly-owned subsidiary of mabcure inc. (otcbb: mbci) , a biotech company that has developed a series of highly specific monoclonal antibodies (mabs) to combat various ” View full resource at medicalnewstoday.com
Most Recently Shared on January 8, 2010 at 9:18 am By:
MabCure Launches Clinical Trial To Diagnose Ovarian Cancer http://mnt.to/3w47
Commencement Of A Phase II Clinical Trial Of SG2000 In Ovarian Cancer
medicalnewstoday.com — “Spirogen Limited (the Company) and Celtic Therapeutics Holdings LP (Celtic Therapeutics) announced the commencement of a Phase II clinical trial of SG2000 in ovarian cancer. The trial is bein” View full resource at medicalnewstoday.com
Most Recently Shared on September 16, 2010 at 2:00 pm By:
MNT Ovarian Cancer Health News
Commencement Of A Phase II Clinical Trial Of SG2000 In Ovarian Cancer http://mnt.to/3JQh #ovariancancer
Medical News:Advanced Ovarian Cancer -- A Clinical Context Report - in Clinical Context, Ovarian Cancer from MedPage Today
medpagetoday.com — “Medical News:Advanced Ovarian Cancer -- A Clinical Context Report - in Clinical Context, Ovarian Cancer from MedPage Today” View full resource at medpagetoday.com
Most Recently Shared on February 28, 2012 at 3:26 pm By:
Advanced Ovarian Cancer -- A Clinical Context Report (CME/CE, with video) http://t.co/ZX5dqi1L
New treatment regimen shown effective against advanced ovarian cancer
physorg.com — “Newly reported results from a major clinical trial show that adding bevacizumab (Avastin) to standard frontline chemotherapy for women with advanced ovarian cancer and then continuing a maintenance dose of the drug afterwards significantly extends progression-free survival. Women receiving the new treatment ...” View full resource at physorg.com
Most Recently Shared on June 6, 2010 at 4:50 pm By:
PhysOrg Health News Health News
New treatment regimen shown effective against advanced ovarian cancer http://tw.physorg.com/195047400
Bevacizumab extends progression-free survival in women with advanced ovarian cancer
news-medical.net — “Newly reported results from a major clinical trial show that adding bevacizumab (Avastin) to standard frontline chemotherapy for women with advanced ovarian cancer and then continuing a maintenance dose of the drug afterwards significantly extends progression-free survival. Women receiving the new treatment regimen saw no worsening of their disease for 14.1 months, compared to 10.3 months for women receiving standard therapy.” View full resource at news-medical.net
Most Recently Shared on June 7, 2010 at 12:55 pm By:
Ovarian Cancer News: Bevacizumab extends progression-free survival in women with advanced ovarian cancer: Newly ... http://buzzup.com/zltp
New treatment regimen shown effective against advanced ovarian cancer
eurekalert.org — “Newly reported results from a major clinical trial show that adding bevacizumab (Avastin) to standard frontline chemotherapy for women with advanced ovarian cancer and then continuing a maintenance dose of the drug afterwards significantly extends progression-free survival. Women receiving the new treatment regimen saw no worsening of their disease for 14.1 months, compared to 10.3 months for women receiving standard therapy.” View full resource at eurekalert.org
Most Recently Shared on June 6, 2010 at 6:53 pm By:
New treatment regimen shown effective against advanced ovarian cancer: (Fox Chase Cancer Center) Newly reported re... http://bit.ly/a8Fohc
Novartis Phase III Trial Examining EPO906 (patupilone) For Patients With Advanced Ovarian Cancer Failed To Meet Primary Endpoint
medicalnewstoday.com — “Novartis announced that patupilone (EPO906) did not show a significant overall survival advantage in a phase III trial of patients with advanced ovarian cancer, refractory or resistant to platinum” View full resource at medicalnewstoday.com
Most Recently Shared on June 1, 2010 at 3:11 pm By:
MNT Ovarian Cancer Health News
Novartis Phase III Trial Examining EPO906 (patupilone) For Patients With Advanced Ovarian Cancer Failed To Meet Primar... http://mnt.to/3DkL
Upcoming Webinar: How Can I Get Involved in Ovarian Cancer Clinical Trials? | Ovarian Cancer National Alliance
ovariancancer.org — “This 90-minute session will cover the basics of cancer clinical trials, including key risks and benefits, myths about clinical trials and how people can be” View full resource at ovariancancer.org
Most Recently Shared on March 31, 2011 at 9:27 pm By:
Paul Cacciatore Patient Advocate
Upcoming OCNA Webinar: How Can I Get Involved in Ovarian Cancer Clinical Trials? http://dld.bz/U6ye
Ovarian Cancer Home Page
cancer.gov — “Information about ovarian cancer treatment, prevention, genetics, causes, screening, clinical trials, research and statistics from the National Cancer Institute.” View full resource at cancer.gov
Most Recently Shared on July 30, 2009 at 7:38 pm By:
Pacific Oncology Physician Group
Estimated new cases and deaths from ovarian #cancer in the United States in 2010: New cases: 21,880 Deaths:... http://fb.me/G63kERqr
Medical News: PARP Inhibitor Active in Non-BRCA Ovarian Ca - in Clinical Context, Ovarian Cancer from MedPage Today
medpagetoday.com — “Advanced ovarian cancer, regardless of BRCA mutations, responded to treatment with PARP inhibitor olaparib, data from an open-label trial showed.” View full resource at medpagetoday.com
Most Recently Shared on August 21, 2011 at 11:02 pm By:
PARP Inhibitor Active in Non-BRCA Ovarian Ca (CME/CE) http://t.co/zSTuvMC
Medical News: PARP Inhibitor Active in Non-BRCA Ovarian Ca - in Clinical Context, Ovarian Cancer from MedPage Today
medpagetoday.com — “Advanced ovarian cancer, regardless of BRCA mutations, responded to treatment with PARP inhibitor olaparib, data from an open-label trial showed.” View full resource at medpagetoday.com
Most Recently Shared on August 21, 2011 at 11:20 pm By:
PARP Inhibitor Active in Non-BRCA Ovarian Ca (CME/CE) http://t.co/44UrrXe
Topotarget Announces Updates on Belinostat in Two Clinical Trials - NSCLC and Ovarian Cancer - Drugs.com MedNews
drugs.com — “Copenhagen, Denmark - 14 March, 2011 - Today Topotarget A S (NASDAQ OMX TOPO.CO) announced updates on belinostat in two clinical trials - NSCLC and ovarian canc” View full resource at drugs.com
Most Recently Shared on March 14, 2011 at 5:02 pm By:
Drugs and Devices OW OW Health
Topotarget Announces Updates on Belinostat in Two Clinical Trials - NSCLC and Ovarian Cancer: Copenhagen, ... http://bit.ly/fLW9VD #drug
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
MNT Ovarian Cancer
The latest ovarian cancer news published daily. Articles from research centers, universities and prestigious journals.
-
News-Medical.Net
Stay up to date with the latest Ovarian Cancer news and research via News-Medical.Net
-
MNT Ovarian Cancer
The latest ovarian cancer news published daily. Articles from research centers, universities and prestigious journals.
Advertisement
